Ben Blackwell is a distinguished Executive Biopharmaceutical Representative at Amgen, specializing in the Inflammation therapeutic area. With a robust background in the biotechnology industry, Ben has garnered recognition for his exceptional sales performance, earning the prestigious Sales Representative of the Year award in 2023 and...
Ben Blackwell is a distinguished Executive Biopharmaceutical Representative at Amgen, specializing in the Inflammation therapeutic area. With a robust background in the biotechnology industry, Ben has garnered recognition for his exceptional sales performance, earning the prestigious Sales Representative of the Year award in 2023 and securing a place in the Chairman's Circle for the same year. His expertise lies in marketing biologic medications, notably Enbrel, and non-biologics like Otezla, targeting specialists in rheumatology and select internal medicine and family practitioners across West Virginia and Ohio.
In his current role, Ben demonstrates a commitment to excellence through national-level execution strategies that enhance the visibility and accessibility of Amgen’s innovative therapies. His adeptness in hospital sales and product launch initiatives has positioned him as a key player in the promotion of advanced treatment options for patients suffering from inflammatory conditions. Ben's comprehensive understanding of the pharmaceutical landscape, combined with his skills in sales training and effectiveness, allows him to build strong relationships with healthcare professionals, ensuring they are well-informed about the latest therapeutic advancements.
Ben's educational background in Sports Medicine and Athletic Training from The University of Charleston complements his professional journey, providing him with a unique perspective on patient care and treatment outcomes. His multifaceted expertise spans various medical specialties, including cardiology, endocrinology, neurology, urology, and nephrology, enabling him to engage effectively with a diverse range of healthcare providers. As he continues to drive sales and foster collaboration within the industry, Ben Blackwell remains a vital asset to Amgen and the broader biopharmaceutical community.
